MedTrace Logo

Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness

NCT00401284 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2008-01-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.

Conditions

  • Sleep Initiation and Maintenance Disorders

Interventions

DRUG

EVT 201

Sponsors & Collaborators

  • Evotec Neurosciences GmbH

    lead INDUSTRY

Principal Investigators

  • James K Walsh, PhD · St Luke's Hospital, Sleep Medicine and Research Center, Chesterfield, MI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00401284 on ClinicalTrials.gov